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The four main Plasmodium species that cause human malaria, Plasmodium falciparum,
Plasmodium vivax, Plasmodiummalariae, and Plasmodium ovale, are transmitted between
humans by mosquito vectors belonging to the genus Anopheles. It has recently become
evident that Plasmodium knowlesi, a parasite that typically infects forest macaque mon-
keys, can be transmitted by anophelines to cause malaria in humans in Southeast Asia.
Plasmodium knowlesi infections are frequently misdiagnosed microscopically as P. malar-
iae. Direct human to human transmission of P. knowlesi by anophelines has not yet been
established to occur in nature. Knowlesi malaria must therefore be presently considered a
zoonotic disease. Polymerase chain reaction is now the definitive method for differentiating
P. knowlesi from P. malariae and other human malaria parasites. The origin of P. falciparum
and P. vivax in African apes are examples of ancient zoonoses that may be continuing at the
present time with at least P. vivax, and possibly P. malariae and P. ovale. Other non-human
primate malaria species, e.g., Plasmodium cynomolgi in Southeast Asia and Plasmodium
brasilianum and Plasmodium simium in South America, can be transmitted to humans by
mosquito vectors further emphasizing the potential for continuing zoonoses. The poten-
tial for zoonosis is influenced by human habitation and behavior as well as the adaptive
capabilities of parasites and vectors. There is insufficient knowledge of the bionomics of
Anopheles vector populations relevant to the cross-species transfer of malaria parasites
and the real extent of malaria zoonoses. Appropriate strategies, based on more research,
need to be developed for the prevention, diagnosis, and treatment of zoonotic malaria.
Keywords: African apes, Anopheles vectors, human malaria, malaria control, malaria transmission, non-human
primate malaria, Plasmodium, zoonosis
INTRODUCTION
The history of the many discoveries made over a period of more
than 100 years showing that human malaria was caused by a pro-
tozoan parasite that is transmitted by mosquito vectors has been
extensively documented [Ref. (1) and references therein]. It is now
known that infections with four species of malaria parasites, viz.
Plasmodium falciparum, Plasmodiummalariae, Plasmodium ovale,
and Plasmodium vivax, transmitted between humans by mosquito
vectors of the genusAnopheles are primarily responsible for human
malaria. The World Health Organization in its latest malaria report
(2) estimated that about 207 million persons had clinical disease
and 627,000 died worldwide from malaria in 2012. Human malaria
is endemic in many parts of sub-Saharan Africa, South and South-
east Asia, and Central and South America (3, 4). About 3.4 billion
people in the world are at risk of malaria, although the risk is
relatively low outside Africa and South/Southeast Asia. P. falci-
parum, the dominant parasite in Africa (3), is responsible for 92%
of the deaths that occur mostly among children living in sub-
Saharan Africa. P. vivax, a common human malaria parasite in
much of Asia and South America (4), is regarded to cause serious
disease but rarely death. However, there are indications that severe
vivax malaria and attendant fatalities may have increased in Asia-
Pacific and South America over the past 5 years (5). P. malariae
and P. ovale are the two other rarer human malaria parasites.
Approximately 250 species of Plasmodium are presently
believed to parasitize mammals, birds, and reptiles. All are trans-
mitted by insect vectors. More than 30 species of Plasmodium
have been reported in non-human primates, including apes, gib-
bons, and New and Old World monkeys. All primate malarias are
believed to be transmitted only by Anopheles mosquitoes.
Some monkey malaria parasites have been experimentally
transmitted to humans in the past through the bites of infected
mosquitoes. They include Plasmodium cynomolgi (6–8), Plasmod-
ium knowlesi (9, 10), and Plasmodium inui (11) from Old World
monkeys, Plasmodium brasilianum (12) and Plasmodium simium
(13) from New World monkeys, and Plasmodium schwetzi (now
regarded to be either P. vivax or P. ovale-like parasites) from chim-
panzees (14). However, recent discoveries, made possible by the
use of polymerase chain reaction (PCR) and high throughput
DNA sequencing, now establish that human malaria can also be a
zoonotic disease.
PLASMODIUM KNOWLESI ZOONOSIS IN ASIA
Natural human infection with P. knowlesi, a common parasite of
mainly macaque (Macaca species) monkeys in Southeast Asia, has
been known to be possible for half a century (15). The more recent
discovery of a focus of human infections in the Kapit division
of the Sarawak state of Malaysian Borneo, however, showed that
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P. knowlesi zoonosis was more prevalent than previously sus-
pected (16). The infections in Kapit were misdiagnosed by routine
microscopy of blood films as being caused mainly by P. malariae.
This is because the late blood stages of P. knowlesi and P. malar-
iae are morphologically very similar. The subsequent retrospective
use of P. knowlesi-specific primers for PCR amplification and DNA
sequencing of the genes for the small subunit ribosomal RNA (ssr-
RNA) and circumsporozoite protein (csp) was essential for correct
species identification in Kapit (16). Human P. knowlesi infections
were subsequently demonstrated in Pahang in peninsular Malaysia
and in Sabah in Malaysian Borneo by species-specific PCR (17). A
more recent retrospective ssrRNA-based PCR analysis of malaria
blood samples showed that human infection with P. knowlesi is
in fact widespread in peninsular Malaysia as well as the states of
Sarawak and Sabah in Malaysian Borneo, accounting for 96% of
all malaria cases in one peninsular hospital (18). Erroneous micro-
scopic identification of P. knowlesi as a human malaria parasite in
blood films was reported to be common in peninsular Malaysia
(18) as was the case in Malaysian Borneo (16, 17). Mixed infec-
tions of P. knowlesi and human malaria parasites in patients have
been observed in both peninsular Malaysia and Malaysian Borneo
(17, 18). The use of DNA-based identification methods has since
documented human P. knowlesi infections in much of Southeast
Asia, ranging from the Andaman and Nicobar islands of India in
the West to the Philippines in the East [Ref. (19) and references
therein].
Plasmodium knowlesi is normally a parasite of Macaca fascic-
ularis (the long-tailed or crab-eating macaque), Macaca nemest-
rina (the pig-tailed macaque),Trachypithecus obscuras (dusky leaf
monkey or spectacled langur), and Presbytis melalophus (banded
leaf monkey or brown langur) [Ref. (19) and references therein].
The main documented vectors are members of the Anopheles leu-
cosphyrus group, some of which have been reported to feed equally
well on humans and monkeys [Ref. (19) and references therein,
Ref. (20)]. Within the leucosphyrus group, Anopheles balabacensis
is a particularly efficient vector of simian P. knowlesi in Malaysia
as is Anopheles dirus in Vietnam [reviewed in Ref. (9, 20, 21)]. A
map of the likely range of P. knowlesi based on the distribution of
host monkey species and the relevant anopheline vectors, suggests
that a potential for P. knowlesi zoonosis exists across large tracts
of the populous South and Southeast Asian region (19). Because
microscopy and rapid diagnostic tests commonly employed to
diagnose malaria lack the requisite specificity, it is possible that
many more patients with P. knowlesi malaria may have been
unknowingly misdiagnosed in South and South East Asia.
Experimental P. knowlesi inoculations have been used in the
past to treat neurosyphilis (9). The parasite has a 24 h asexual cycle
in blood and therefore produces a quotidian fever that can poten-
tially differentiate it from the 72 h quartan fever of P. malariae
infections in humans. However, the clinical symptoms of natu-
rally acquired P. knowlesi infections in humans are often not very
specific and the infections can sometimes prove severe and fatal
with high parasitemias [Ref. (9) and references therein]. Mixed
infections of P. knowlesi with human malaria parasites are not
uncommon in patients (17, 18, 21) and human infection with P.
knowlesi in some sites in Vietnam has been reported to be asymp-
tomatic (21). This contrasts with the milder symptoms and lower
parasitemias observed with P. knowlesi in its natural monkey hosts
(9). More extensive investigations on the clinical features and treat-
ments of P. knowlesi infections in humans are warranted by the
increasing realization that such infections are more common than
previously reported in countries like Malaysia (18). From the treat-
ment point of view, it is relevant to note that P. knowlesi strains
from patients in Malaysian Borneo were reported to be sensitive
to artemisinins, moderately but variably sensitive to chloroquine,
and less sensitive to mefloquine (22). It is not clear whether the less
than desirable sensitivity of P. knowlesi to chloroquine and meflo-
quine is a result of drug selection in humans and/or the intrinsic
biology of the parasite, and this merits further investigation.
Despite the experimental transfer of P. knowlesi infections to
humans and documented natural infections in Southeast Asia, the
direct transfer of P. knowlesi from one infected person to another
uninfected human by mosquito vectors has yet to be unequivo-
cally demonstrated to occur in nature. Rather, human infections
appear to be acquired from monkeys when people venture into
forests. Epidemics of P. knowlesi malaria have not been reported
and clustering of infections was not observed at Kapit, Sarawak
in Malaysian Borneo (16). However, P. knowlesi is able to form
mature gametocytes in the blood of infected persons (23, 24). P.
knowlesi sporozoites are also detectable in the salivary glands of
An. dirus, a human malaria vector in Vietnam, commonly as mixed
infections with P. vivax and P. falciparum sporozoites (21). The
existing data therefore raise the possibility that human to human
transmission of P. knowlesi may occur in areas with a high density
of P. knowlesi zoonosis. However, there is presently no evidence
to firmly establish that such transmission takes place, and if it
does occur, the possible rates of knowlesi malaria transmission
between humans and its epidemiological significance need to be
investigated.
PLASMODIUM CYNOMOLGI ZOONOSIS IN ASIA
The experimental infection of humans with P. cynomolgi, com-
monly a parasite of macaque monkeys in Asia, through the bites
of infected Anopheles freeborni mosquitoes was demonstrated
half a century ago (6). However, the first natural infection of a
human was only reported very recently in peninsular Malaysia
(25). Microscopic examination of the blood film from this patient
suggested infection with P. vivax. P. cynomolgi blood stages are
morphologically very similar to those of P. vivax. A common
nested PCR test (26) yielded an amplified fragment of ssrRNA
whose size was characteristic of P. vivax. A more discriminating
PCR followed by DNA sequencing of ssrRNA, however, showed
conclusively that the parasite causing the infection was in fact
P. cynomolgi (25). The clinical presentation of this patient was
mild with 24 h cyclic chills rather than the expected tertian fever
resulting from the 48 h asexual blood stage cycle of P. cynomolgi.
The patient lived adjacent to a small forest where macaques
were present. The suspected mosquito vector in this case was
Anopheles cracens, belonging to theAn. leucosphyrus group of mos-
quitoes, and a known vector of the simian malaria parasites P.
cynomolgi and P. inui (25). This case suggests that other instances
of human infections with P. cynomolgi in South and Southeast
Asia may have been similarly misdiagnosed as P. vivax infections
by microscopy.
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PLASMODIUM SIMIUM AND PLASMODIUM BRASILIANUM
AS ZOONOSES IN THE NEWWORLD
Plasmodium simium is a parasite of the platyrrhine monkeys of
South America. The New World platyrrhine monkeys diverged
from catarrhine monkeys of the Old World about 30–35 million
years ago (27). Sequence analysis of genes coding for the merozoite
surface protein-1 (msp1) and cytochrome b (cytb) and the ssrRNA
and csp genes from worldwide isolates of P. vivax and a limited
number of P. simium isolates from South America showed that the
two parasites were very closely related (28). It is unlikely that P.
vivax originated in the New World from P. simium because there is
now evidence to show that P. vivax in humans arose from related
parasites in African apes (29). This conclusion is supported by
the greater genetic diversity of P. vivax worldwide compared to P.
simium, which is found only in South America (28). It is therefore
more likely that P. simium arose from P. vivax that was transferred
to platyrrhine monkeys by infections prevalent in settlers from
the Old World in the post-Columbus era. At least two such cross-
species transfers must have taken place as two different alleles of
the P. vivax csp are also found in P. simium (28).
Natural infection of a human by P. simium was reported from
Brazil in 1966 (13). A volunteer collecting mosquitoes by human
landing catches in a forest became infected with the parasite, which
was identified by careful microscopic examination of blood films
to be P. simium. The infection could be syringe-transferred from
his blood to a platyrrhine squirrel monkey (Saimiri spp.) It was
suspected that platyrrhine howler monkeys (Alouatta fusca) were
the original source of the infection, and Anopheles cruzi the vector,
in this instance of zoonosis. It was suggested that human P. sim-
ium infections contracted in forests may often be misdiagnosed as
P. vivax during routine microscopy due to the presence of simi-
lar patterns of stippling or Schuffner’s dots in infected red blood
cells, and because many microscopists might be unaware of the
possibility of simian malaria parasites infecting humans (13).
Plasmodium brasilianum is a parasite of many species of
platyrrhine monkeys in South and Central America. Sequence
analysis of csp, msp1, and ssrRNA of P. malariae and P. brasil-
ianum showed that the two parasites were very closely related but
the likely direction of a cross-species transfer could not be estab-
lished due to the limited number of parasite isolate sequences
available for analysis (28). There is now evidence to suggest that
parasites closely related to P. malariae are found in African apes
(30, 31). If it can be shown that P. malariae in man, like P. fal-
ciparum (30) and P. vivax (29), also arose through cross-species
transfer from African apes in Africa, it would appear plausible
that P. brasilianum in platyrrhines is a result of the cross-species
transfer of P. malariae brought to the New World by settlers in the
post-Columbus era.
Anopheles freeborni mosquitoes infected by feeding on a
platyrrhine spider monkey,Ateles geoffroyi geoffroyi, from Panama
carrying P. brasilianum, have been shown to transmit the parasite
through biting to five human volunteers (12). This raises the pos-
sibility that the transmission of P. brasilianum from platyrrhine
monkey hosts to humans occurs naturally in South and Cen-
tral America with the resulting human infections being diagnosed
as P. malariae by microscopy and other diagnostic tests. Since
very few gene sequences are available for the two species, and
the existing ones show little difference between them, establish-
ing zoonosis through DNA-based diagnostics is difficult at the
present time. It also seems likely that P. malariae and P. brasil-
ianum are in fact variants of the same parasite species that are
able to infect both humans and platyrrhine monkeys in the New
World.
PLASMODIUM FALCIPARUM AS AN ANCIENT ZOONOSIS
IN AFRICA
It was believed for some time, based on limited DNA sequencing,
that the closest relative to humanP. falciparum was the chimpanzee
(Pan troglodytes) parasite Plasmodium reichenowi (32). The ori-
gin of P. falciparum was, however, recently established through
sequencing a number of genes from parasite DNA isolated from
fecal samples of wild apes in Africa (30). DNA sequence analysis
showed that parasites more closely related to P. falciparum than P.
reichenowi are prevalent in western gorillas (Gorilla gorilla) in West
and Central African forests. Analysis of the sequences of the mito-
chondrial cytb showed that the P. falciparum-related ape parasites
could be phylogenetically classified into six host-specific clades
(30) tentatively named as P. reichenowi, Plasmodium gaboni, and
Plasmodium billicollinsi in chimpanzees and Plasmodium praefal-
ciparum,Plasmodiumadleri, andPlasmodiumblacklocki in western
gorillas (33). All known human P. falciparum cytb sequences
formed a distinct lineage within the gorilla-specific P. praefalci-
parum clade (30). Analysis of the apicoplast caseinolytic protease
C (clpC) and nuclear lactate dehydrogenase (ldh) genes, and the
entire mitochondrial genome, yielded a phylogenetic relationship
compatible to that obtained with cytb. Therefore, P. falciparum
most probably arose through the cross-species transfer of an
ancestral P. praefalciparum-like parasite from gorillas that then
successfully adapted itself to humans (30). Anopheles moucheti,
a known human malaria vector that is found in forested areas of
Central Africa, has been shown to carryP. praefalciparum in Gabon
(34). Inoculation of P. praefalciparum into humans is therefore
very likely to be a continuing process in West and Central Africa but
productive infections in potentially exposed humans in Cameroon
were not detected and are therefore likely to be extremely rare (35).
However, more studies involving other African sites are needed to
further clarify this aspect.
Apes are not readily infected with P. falciparum and in order to
obtain high parasitemia, chimpanzees have to be splenectomized
(36). Platyrrhine owl (Aotus spp.) and squirrel (Saimiri spp.)
monkeys are also infectible with P. falciparum, but a period of
adaptation in splenectomized animals is required (36). It has been
proposed that the adaptation and host specificity of P. falciparum
for humans is a result of the specific interaction of a P. falci-
parum protein ligand PfEBA175 with N -acetylneuraminic acid
on human erythrocyte glycophorin A (37). However, more recent
evidence suggests that the specificity may be due to the interac-
tion between PfRh5, an essential erythrocyte invasion ligand found
in the rhoptry organelles of the parasite, and the corresponding
human erythrocyte receptor termed basigin (38). Basigin or CD
147 is responsible for the Ok blood group phenotype. PfRh5 does
not bind gorilla basigin and only binds weakly to chimpanzee
basigin and these properties have been suggested to cause the host
restriction of P. falciparum to humans (38).
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Analysis of single nucleotide polymorphisms (SNPs) in two
P. falciparum genes for common housekeeping proteins (P
type Ca2+-ATPase, serca, and adenylosuccinate lyase, adsl), from
parasite isolates in different parts of the Old World showed that
genetic diversity in P. falciparum decreased significantly with the
distance from sub-Saharan Africa (39). This finding may be inter-
preted as being compatible with a hypothesis that the carriage of P.
falciparum from an origin in sub-Saharan Africa to the Old World
was a result of the migration of modern humans (Homo sapiens)
and/or ancestral Homo species to whom P. falciparum had become
adapted.
PLASMODIUM VIVAX AS AN ANCIENT AND CONTINUING
ZOONOSIS IN AFRICA
Sequence analysis of mitochondrial DNA from ape fecal and mon-
key blood samples in tropical sub-Saharan African forests also
show that Plasmodium parasites genetically very similar to human
P. vivax are common in wild chimpanzees (P. troglodytes) and
western (G. gorilla) and eastern gorillas (Gorilla beringei) but
not bonobos (Pan paniscus) or monkeys (29). Human P. vivax
sequences from different parts of the world formed a distinct lin-
eage within the ape sequences but the data suggest that the ape
and human parasites belong to a single species, P. vivax. Analysis
of the apicoplast clpC and four nuclear genes (ldh, asl coding for
adenylosuccinate lyase, β-tub coding for β tubulin and crk-2 cod-
ing for cell division cycle 2-related kinase) also produced results
that were consistent with this conclusion (29).
Plasmodiumvivax uses the Duffy blood group antigen molecule
on red blood cells as the main receptor for binding and subsequent
invasion. There are three major alleles for the antigen, viz. FY*A
and FY*B, which differ by a single amino acid, and FY*O that gives
rise to the absence of the receptor and the Fy(a-b-) serological
phenotype in homozygous individuals. The Fy(a-b-) phenotype
has been commonly associated with near complete resistance to P.
vivax in most of Africa (40). The FY*O allele is estimated to have
been selected in Africa approximately 33,000 years ago, i.e., after
the initial migration of H. sapiens out of Africa, probably because
of the protection provided against vivax malaria (41). However,
approximately 5% of West Africans and a greater proportion of
East Africans remain Duffy antigen positive and there is also evi-
dence that P. vivax has evolved to use receptors other than the
Duffy blood group antigen in East and West Africa (42–44).
The greater similarity of human P. vivax to ape P. vivax
than human P. falciparum to gorilla P. praefalciparum, suggests
that there may be continuing cross-species exchange of P. vivax
between humans and apes in tropical Africa. Zoonosis was recently
confirmed by sequence analysis of parasite DNA from a Cau-
casian European traveler, who contracted P. vivax-like malaria
while working in the Central African Republic, which showed that
the parasite had SNPs characteristic of ape and not human P. vivax
(45).P. vivax with SNPs reportedly characteristic of humanP. vivax
has been identified in African apes confirming that the reverse
transfer is also possible (45). Anopheles moucheti and Anopheles
vinckei have been shown to carry ape-like P. vivax in Gabon and
are potential vectors for zoonotic transmission to humans in or
near forests (34, 45). The Fy(a-b-) phenotype or the absence of
the Duffy antigen in a majority of the West and Central Africans
would, however, protect against zoonotic P. vivax but such pro-
tection will not apply to the minority of Duffy antigen positive
Africans and non-native populations or infection with P. vivax
strains that can use alternative red blood cell receptors for inva-
sion. Recent evidence suggests that Duffy antigen negative persons
in Congo have antibodies specific for P. vivax asexual blood stage
antigens (46) and that blood stage P. vivax infections can be
detected by PCR in Duffy antigen positive and negative asymp-
tomatic individuals in Cameroon (47). These recent observations
are consistent with a proposal that Duffy antigen positive apes are
a reservoir of P. vivax in West and Central Africa for transmission
to humans to produce mild infections and elicit antibodies (48).
More studies are clearly needed to determine the nature and extent
of P. vivax zoonosis in Africa.
PLASMODIUMMALARIAE AND PLASMODIUM OVALE AS
POSSIBLE ANCIENT AND CONTINUING ZOONOSES IN
AFRICA
Studies in the 1940s by Rhodain suggested that a chimpanzee
(P. troglodytes) parasite Plasmodium rhodaini was very similar, if
not identical, to the human quartan malaria parasite P. malariae,
with both parasites being readily transferable between humans
and chimpanzees [reviewed in Ref. (49)]. Analysis of a limited
number of cytb and ssrRNA sequences available now suggests that
both P. malariae and P. ovale have closely related counterparts in
wild chimpanzees in tropical Africa (30, 31). A larger number of
P. malariae and P. ovale and ape sequences are needed for detailed
analyses for determining the likely ancestral parasites of the two
human species. Presently available data are, however, compatible
with a hypothesis that human P. malariae and P. ovale, like P. fal-
ciparum and P. vivax, originated by cross-species transfer from
African apes and then spread worldwide. Testing this hypothesis
would require DNA sequences from a greater number of human
P. malariae and P. ovale isolates worldwide and isolates of related
parasites from wild African apes.
UNDER-DIAGNOSIS OF ZOONOTIC INFECTIONS IN HUMANS
The continuing difficulty in correctly identifying P. knowlesi in
Southeast Asia, because of its similarity to P. malariae in blood
films as discussed in Section “Plasmodium knowlesi Zoonosis
in Asia” above, illustrates the potential for under-diagnosis of
other forms of zoonotic malaria in many parts of the world.
Microscopists working in hospitals and health centers in malaria-
endemic countries where zoonoses may occur are not likely to
differentiate between human parasites and closely related zoonotic
parasites when routinely screening blood films. Antibody-based
rapid diagnostic kits suitable for detectingP. knowlesi in blood with
acceptable specificity and sensitivity are not presently available
(50). It has also been suggested that presumptive drug treatment
of malaria-like symptoms, and the lack of resistance to common
anti-malarial drugs in P. praefalciparum, can rapidly cure zoonotic
infections so that such infections may therefore go undetected
in sub-Saharan Africa (33). Zoonotic malaria species may also
develop low parasitemias in humans, so that their presence may
be masked by coinfection with more virulent human species like
P. falciparum. This has been observed for P. knowlesi in Vietnam
(21). The availability of SNPs specific for ape parasites (e.g., for
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Table 1 | Documented ongoing malaria zoonoses.
Plasmodium species Location Reference
P. knowlesi Southeast Asia (15–21)
P. cynomolgi Malaysia (25)
P. vivax West Africa (45)
P. vivax /P. simium South America (13)
P. praefalciparum and ape P. vivax) will facilitate identification
of zoonotic infections as already demonstrated for P. vivax (45).
However, ape malarial parasites related to P. falciparum including
P. praefalciparum were not detected in humans who are likely to
have been inoculated with such parasites by mosquito vectors in
remote rural areas of Cameroon (35). Such DNA-based tests are
not available for routine identification of zoonotic malaria para-
sites in malaria-endemic countries. They have also not yet been
developed for P. malariae and P. ovale in Africa and may not be
applicable in South America for differentiating P. simium from P.
vivax and P. brasilianum from P. malariae.
Of the many Plasmodium species known to parasitize non-
human primates, only a few species have been shown to be
naturally transmitted to humans at the present time (Table 1).
Although experimentally transmissible to humans (11), natural
human infection with P. inui has not yet been documented. The
absence of suitable diagnostic methods may explain the failure
to detect P. inui, and perhaps many other non-human primate
malaria parasite species, in humans. However, there are several
possible causes that can prevent such other non-human pri-
mate Plasmodium species from naturally infecting humans. These
include the inability to infect and form sporozoites in mosquito
vectors that feed on humans, susceptibility to human innate
immune responses, absence of compatible parasite ligands and
human erythrocyte and hepatocyte receptors that facilitate pro-
ductive invasion, and existence of intracellular hurdles that bar
development even if host cell invasion were to be successfully
achieved.
CHANGES IN HUMAN HABITATION AND ECOLOGY AS WELL
AS ADAPTIVE CHANGES IN PARASITES AND VECTORS MAY
FACILITATE THE EMERGENCE OF NEW HUMANMALARIA
PARASITES FROM NON-HUMAN PRIMATES
Increasing populations coupled with a demand for more agri-
cultural land and timber is leading to extensive deforestation in
malaria-endemic countries of the tropics. Humans are also ventur-
ing into forested areas in greater numbers for mining, lumbering,
and recreation, and more people are beginning to live close to
forests. Wild ape populations are also diminishing in Africa as are
wild monkey populations throughout the world (51). Anopheline
vectors that are responsible for sylvatic transmission of malaria
parasites are therefore likely to be faced with decreasing numbers of
monkey and ape hosts and increasing numbers of potential human
hosts. Examples of anopheline malaria vectors becoming more
anthropophilic over the course of a few years as a result of a short-
age of animal hosts have been long documented (52). Mosquito
vectors are generally highly versatile in adapting to environmental
changes (53). Therefore, it is likely that ongoing changes in human
habitation patterns and ecology as well as vector adaptation will
lead to an increasing probability of humans becoming inoculated
with monkey and ape malaria parasites and vice versa. In rare
cases, such cross-species transfer may result in a non-human pri-
mate Plasmodium species varying sufficiently to adapt itself to
human–human transmission, as was the likely case for the ances-
tor of P. falciparum. There is also the rare possibility that human
malaria parasites may undergo genetic recombination with closely
related ape and monkey parasites to yield new parasite strains that
are more virulent to humans. Malaria parasites are haploid in their
primate hosts, and meiosis and zygote formation takes place in the
mid gut of mosquitoes. Genetic recombination between different
P. falciparum strains occurs in mosquitoes (54). A mosquito vec-
tor infected with gametocytes of two closely related human and
non-human primate parasites at the same time can theoretically
serve as a vehicle for similar genetic recombination. Such a mix of
gametocytes can be acquired through rapid sequential blood meals
on infected humans and non-human primates in forested areas or
in the case of P. vivax be acquired from a co-infected human or
non-human primate. P. vivax may be particularly prone to such a
recombination process since it appears to be readily able to switch
between apes and humans in Africa as discussed in Section “Plas-
modium vivax as an Ancient and Continuing Zoonosis in Africa”
and between platyrrhine monkeys and humans in South Amer-
ica as discussed in Section “Plasmodium simium and Plasmodium
brasilianum as Zoonoses in the New World.”An epidemiologically
pertinent but molecularly distant example from another pathogen
is the swine influenza variant 2009 A (H1N1) that caused the 2009
influenza pandemic. It contained many genetic re-assortments
with common swine influenza virus genes that resulted greater
pathogenicity to humans (55). Genetic recombination is, how-
ever, likely to occur much less frequently with malaria parasites
than influenza viruses because of the much greater complexity
associated with the parasite sexual recombination process, but the
possibility nevertheless needs to be borne in mind.
RESEARCH AND POLICY NEEDS
Not enough is presently known about the bionomics of anopheline
vectors that transmit ape and monkey malaria parasites that are
closely related to the human ones. This is more so in tropical Africa
and South America than Asia. Details of their feeding preference
for human and non-human primate hosts, resting habits, dispersal
distances after blood feeding, insecticide sensitivities, and ongoing
adaptation to ecological changes are essential for evaluating the
potential role of such vectors in zoonoses. Conversely, there is a
need to determine the extent to which the more anthropophilic
vectors of human malaria feed on apes and monkeys and transmit
malaria parasites.
There is also a need for more studies on the sensitivities of
zoonotic parasites to common anti-malarial drugs used to treat
human malaria and the clinical features of the different types of
zoonotic malarias in humans.
The importance of investigating possible zoonoses in commu-
nities living in close proximity to forests and people venturing
into forests needs to be understood by public health personnel
responsible for malaria detection and control. They need acces-
sible resources, such as a collaborating laboratory, to identify
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suspected cases of zoonotic malaria with DNA-based techniques.
Development, if possible, of non-radioactive DNA probes and
loop-mediated isothermal amplification of DNA (LAMP)-based
diagnostic techniques (56) that can be used for detecting zoonotic
species in endemic country laboratories will be particularly helpful
in this regard.
Zoonoses, particularly the existence of sylvatic reservoirs of
P. vivax and P. malariae in South America and Africa, can com-
promise malaria control and eradication efforts. This needs to
be recognized by the public health authorities responsible for
malaria control. In a broader context, the agencies responsible
for health and environmental planning in the tropics need to be
aware of the present and likely future changes in levels of expo-
sure to zoonotic malaria and develop appropriate mitigating and
preventive strategies.
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